Company Search:
Advanced Search
Sponsored Links
Sopharma AD Company Snapshot
Sopharma AD operates in the Drug stores and proprietary stores sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sopharma AD with three other drug stores in Europe: Medios AG of GERMANY (2020 sales of 626.54 million Euros [US$750.35 million] of which 90% was SPECIALTY-PHARMA TRADE), Sopharma Trading AD (1.17 billion Bulgarian Levas [US$713.69 million] ), and Clinigen Group PLC which is based in UNITED KINGDOM (£504.30 million [US$694.63 million] of which 39% was Unlicensed Medicines).

Sales Analysis. Sopharma AD reported sales of 1.45 billion Bulgarian Levas (US$887.26 million) for the year ending December of 2020. This represents an increase of 12.0% versus 2019, when the company's sales were 1.29 billion Bulgarian Levas. This was the fourth straight year of sales growth at Sopharma AD.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sopharma AD
  Stock Performance Chart for Sopharma AD
  Stock Data: Recent Stock Performance:
  Current Price (4/9/2021): 3.30
(Figures in Bulgarian Levas)
1 Week -1.8%   13 Weeks 1.2%  
4 Weeks 3.1%   52 Weeks 10.0%  
Sopharma AD Key Data:
  Ticker: SFA Country: Bulgaria
  Exchanges: BGR Major Industry: Food & Drug Retailing
    Sub Industry: Drug Stores & Proprietary Stores
  2020 Sales 1,448,899,000
(Year Ending Jan 2021).
Employees: 5,163
  Currency: Bulgarian Levas Market Cap: 414,758,626
  Fiscal Yr Ends: December Shares Outstanding: 125,684,432
  Share Type: Closely Held Shares: 71,227,211
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.